Similarly, NGF promotes angiogenesis in breast cancer by increasing the invasion and cord formation of endothelial cells, and antibody-based neutralization inhibits this in vivo [63], leading NGF to be considered a candidate for therapeutic intervention [64]. This evidence concerns the gene NGF and breast carcinoma.